| First Author | Cho K | Year | 2021 |
| Journal | Biochem Biophys Res Commun | Volume | 559 |
| Pages | 21-27 | PubMed ID | 33933990 |
| Mgi Jnum | J:305525 | Mgi Id | MGI:6705996 |
| Doi | 10.1016/j.bbrc.2021.04.089 | Citation | Cho K, et al. (2021) Suppressor of cytokine signaling 2 is induced in Huntington's disease and involved in autophagy. Biochem Biophys Res Commun 559:21-27 |
| abstractText | Suppressor of cytokine signaling (SOCS) proteins are primarily feedback inhibitors of cytokine signaling. The two conserved domains of SOCS proteins have distinct functions. Src homology 2 (SH2) domain inhibits cytokine receptor, while SOCS box acts as an E3 ubiquitin ligase. SOCS2, a cytokine signaling suppressor, has been primarily implicated in regulating inflammatory conditions in neuronal diseases. However, SOCS proteins have been suggested to play diverse roles in healthy and diseased nervous system including neurodegenerative disorders. In this study, SOCS2 was found to be upregulated in Huntington's disease and was substantially induced in extended polyglutamine (polyQ)-expressing striatal cells. The induced level was augmented under aging conditions. In extended polyQ-expressing cells, downregulated SOCS2 improved autophagic dysfunction rather than altered inflammatory conditions. Overall, we suggest that SOCS2 involves in regulating autophagy by functioning as an E3 ligase in extended polyQ conditions, and consequently regulates cell damage and cell death type. |
